___

• Aksan A, Özdemir A. Endocrine disruptors. Hacettepe University Faculty of Health Sciences Journal. 2016;3(2):1-14.
• Wuttke W, Jarry H, Seidlova-Wuttke D. Definition, classification and mechanism of action of endocrine disrupting chemicals. Hormones. 2010;9(1):9-15.
• Kabir ER, Rahman MS, Rahman I. A review on endocrine disruptors and their possible impacts on human health. Environmental Toxicology and Pharmacology. 2015;40(1):241-58.
• Maqbool F, Mostafalou S, Bahadar H, Abdollahi M. Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms. Life Sciences. 2016;145:265-73.
• Rattan S, Zhou C, Chiang C, Mahalingam S, Brehm E, Flaws JA. Exposure to endocrine disruptors during adulthood: consequences for female fertility. Journal of Endocrinology. 2017;233(3):R109-R29.
• Monneret C. What is an endocrine disruptor? Comptes Rendus Biologies. 2017;340(9-10):403-5.
• Gálvez-Ontiveros Y, Páez S, Monteagudo C, Rivas A. Endocrine disruptors in food: impact on gut microbiota and metabolic diseases. Nutrients. 2020;12(4):1158.
• Petrakis D, Vassilopoulou L, Mamoulakis C, et al. Endocrine disruptors leading to obesity and related diseases. International Journal of Environmental Research and Public Health. 2017;14(10):1282.
• González-Casanova JE, Pertuz-Cruz SL, Caicedo-Ortega NH, Rojas-Gomez DM. Adipogenesis regulation and endocrine Disruptors: Emerging ınsights in obesity. BioMed Research International. 2020;2020:7453786.
• Mezcua M, Martínez-Uroz M, Gómez-Ramos M, Gómez M, Navas J, Fernández-Alba A. Analysis of synthetic endocrine-disrupting chemicals in food: a review. Talanta. 2012;100:90-106.
• Hatch EE, Nelson JW, Stahlhut RW, Webster TF. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. International Journal of Andrology. 2010;33(2):324-32.
• Nadal A, Quesada I, Tudurí E, Nogueiras R, Alonso-Magdalena P. Endocrine-disrupting chemicals and the regulation of energy balance. Nature Reviews Endocrinology. 2017;13(9):536-46.
• Bhandari R, Xiao J, Shankar A. Urinary bisphenol A and obesity in U.S. children. American Journal of Epidemiology. 2013;177(11):1263-70.
• Li D-K, Miao M, Zhou Z, et al. Urine Bisphenol-A level in relation to obesity and overweight in school-age children. PLOS ONE. 2013;8(6):e65399.
• Muscogiuri G, Barrea L, Laudisio D, Savastano S, Colao A. Obesogenic endocrine disruptors and obesity: myths and truths. Archives of Toxicology. 2017;91(11):3469-75.
• Tordjman K, Grinshpan L, Novack L, et al. Exposure to endocrine disrupting chemicals among residents of a rural vegetarian/vegan community. Environment International. 2016;97:68-75.
• Velmurugan G, Ramprasath T, Gilles M, Swaminathan K, Ramasamy S. Gut microbiota, endocrine-disrupting chemicals, and the diabetes epidemic. Trends in Endocrinology and Metabolism: TEM. 2017;28(8):612-25.
• Sargis RM, Simmons RA. Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors. Diabetologia. 2019;62(10):1811-22.
• Ruzzin J, Petersen R, Meugnier E, et al. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ Health Perspect. 2010;118(4):465-71.
• Wu H, Bertrand KA, Choi AL, et al. Persistent organic pollutants and type 2 diabetes: a prospective analysis in the nurses' health study and meta-analysis. Environ Health Perspect. 2013;121(2):153-61.
• Song Y, Chou EL, Baecker A, et al. Endocrine-disrupting chemicals, risk of type 2 diabetes, and diabetes-related metabolic traits: A systematic review and meta-analysis. J Diabetes. 2016;8(4):516-32.
• Yilmaz B, Terekeci H, Sandal S, Kelestimur F. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Reviews in Endocrine & Metabolic Disorders. 2020;21(1):127-47.
• Heindel JJ, Blumberg B, Cave M, et al. Metabolism disrupting chemicals and metabolic disorders. Reproductive Toxicology (Elmsford, NY). 2017;68:3-33.
• Tudurí E, Marroqui L, Dos Santos RS, Quesada I, Fuentes E, Alonso-Magdalena P. Timing of Exposure and Bisphenol-A: Implications for Diabetes Development. Front Endocrinol (Lausanne). 2018;9:648.
• Whitehead R, Guan H, Arany E, Cernea M, Yang K. Prenatal exposure to bisphenol A alters mouse fetal pancreatic morphology and islet composition. Hormone Molecular Biology and Clinical Investigation. 2016;25(3):171-9.
• Alonso-Magdalena P, García-Arévalo M, Quesada I, Nadal Á. Bisphenol-A treatment during pregnancy in mice: a new window of susceptibility for the development of diabetes in mothers later in life. Endocrinology. 2015;156(5):1659-70.
• Kirkley AG, Sargis RM. Environmental endocrine disruption of energy metabolism and cardiovascular risk. Current Diabetes Reports. 2014;14(6):494.
• Fu X, Xu J, Zhang R, Yu J. The association between environmental endocrine disruptors and cardiovascular diseases: A systematic review and meta-analysis. Environ Res. 2020;187:109464.
• Li Y-F, Canário AVM, Power DM, Campinho MA. Ioxynil and diethylstilbestrol disrupt vascular and heart development in zebrafish. Environment International. 2019;124:511-20.
• Lombó M, González-Rojo S, Fernández-Díez C, Herráez MP. Cardiogenesis impairment promoted by bisphenol A exposure is successfully counteracted by epigallocatechin gallate. Environmental Pollution. 2019;246:1008-19.
• Gore AC, Chappell VA, Fenton SE, et al. EDC-2: the Endocrine Society's second scientific statement on endocrine-disrupting chemicals. Endocrine Reviews. 2015;36(6):E1-E150.
• Melzer D, Osborne NJ, Henley WE, et al. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation. 2012;125(12):1482-90.
• Trasande L, Zoeller RT, Hass U, et al. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology. 2016;4(4):565-72.
• Troisi R, Titus L, Hatch EE, et al. A prospective cohort study of prenatal diethylstilbestrol exposure and cardiovascular disease risk. The Journal of Clinical Endocrinology and Metabolism. 2018;103(1):206-12.
• Desai M, Jellyman JK, Ross MG. Epigenomics, gestational programming and risk of metabolic syndrome. International Journal of Obesity. 2015;39(4):633-41.
• Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect. 2008;116(12):1642-7.
• Wei J, Lin Y, Li Y, et al. Perinatal Exposure to Bisphenol A at Reference Dose Predisposes Offspring to Metabolic Syndrome in Adult Rats on a High-Fat Diet. Endocrinology. 2011;152(8):3049-61.
• Behr M, Oehlmann J, Wagner M. Estrogens in the daily diet: in vitro analysis indicates that estrogenic activity is omnipresent in foodstuff and infant formula. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association. 2011;49 10:2681-8.
• Rashid H, Alqahtani S, Alshahrani S. Diet: A source of endocrine disruptors. Endocrine, Metabolic & Immune Disorders - Drug Targets. 2019;19.
• Wittassek M, Koch HM, Angerer J, Brüning T. Assessing exposure to phthalates - the human biomonitoring approach. Molecular Nutrition & Food Research. 2011;55(1):7-31.
• Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ. Phytoestrogens: recent developments. Planta Medica. 2003;69(7):589-99.
• Kaufman PB, Duke JA, Brielmann H, Boik J, Hoyt JE. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. Journal of ALTERNATIVE and Complementary Medicine (New York, NY). 1997;3(1):7-12.
• Troisi J, Richards S, Symes S, et al. A comparative assessment of metals and phthalates in commercial tea infusions: A starting point to evaluate their tolerance limits. Food Chemistry. 2019;288:193-200.
• Mozaffarian D, Rimm EB. Fish Intake, Contaminants, and Human Health Evaluating the Risks and the Benefits. Jama. 2006;296(15):1885-99.
• Sakhi AK, Lillegaard IT, Voorspoels S, et al. Concentrations of phthalates and bisphenol A in Norwegian foods and beverages and estimated dietary exposure in adults. Environ Int. 2014;73:259-69.
• Fierens T, Van Holderbeke M, Willems H, De Henauw S, Sioen I. Transfer of eight phthalates through the milk chain--a case study. Environ Int. 2013;51:1-7.
• Mukherjee R, Pandya P, Baxi D, Ramachandran AV. Endocrine Disruptors–‘Food’ for Thought. Proceedings of the Zoological Society. 2021.
• Pacyga DC, Sathyanarayana S, Strakovsky RS. Dietary Predictors of Phthalate and Bisphenol Exposures in Pregnant Women. Advances in Nutrition (Bethesda, Md). 2019;10(5):803-15.
• Cao XL, Perez-Locas C, Dufresne G, et al. Concentrations of bisphenol A in the composite food samples from the 2008 Canadian total diet study in Quebec City and dietary intake estimates. Food Additives & Contaminants Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment. 2011;28(6):791-8.
• Filardi T, Panimolle F, Lenzi A, Morano S. Bisphenol A and Phthalates in diet: An emerging link with pregnancy complications. Nutrients. 2020;12(2):525.
• Santonicola S, Ferrante M, Leo G, Murru N, Anastasi A, Mercogliano R. Study on endocrine disruptors levels in raw milk from cow’s farms: Risk assessment. Italian Journal of Food Safety. 2018;7.
• Dudarev AA, Chupakhin VS, Vlasov SV, Yamin-Pasternak S. Traditional diet and environmental contaminants in Coastal Chukotka II: Legacy POPs. Int J Environ Res Public Health. 2019;16(5).
• Plotan M, Elliott CT, Frizzell C, Connolly L. Estrogenic endocrine disruptors present in sports supplements. A risk assessment for human health. Food Chemistry. 2014;159:157-65.